A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
Public ClinicalTrials.gov record NCT05831111. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, 2-Part, Dose-Ranging Study of an EBV Candidate Vaccine, mRNA-1195, in Healthy Participants 18 Through 55 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and reactogenicity of mRNA-1195 in healthy participants.
Study identification
- NCT ID
- NCT05831111
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 482 participants
Conditions and interventions
Conditions
Interventions
- mRNA-1195.1 Biological
- mRNA-1195.2 Biological
- mRNA-1189 Biological
- Placebo Biological
- mRNA-1195 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 5, 2023 (Actual)
- Primary completion
- Oct 13, 2026 (Estimated)
- Completion
- Oct 13, 2026 (Estimated)
- Last update posted
- Aug 11, 2026
2023 – 2026
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group, LLC | Anniston | Alabama | 36207 | — |
| Noble Clinical Research | Tucson | Arizona | 85704 | — |
| Marvel Clinical Research | Huntington Beach | California | 92647 | — |
| Tekton Research | Longmont | Colorado | 80501 | — |
| Suncoast Research Group, LLC | Miami | Florida | 33135 | — |
| Velocity Clinical Research | Savannah | Georgia | 31406 | — |
| DM Clinical Research- Chicago | Melrose Park | Illinois | 60160 | — |
| Optimal Research | Peoria | Illinois | 61614 | — |
| Velocity Clinical Research | Sioux City | Iowa | 51106 | — |
| Johnson County Clin-Trials, Inc (JCCT) | Lenexa | Kansas | 66219 | — |
| Velocity Clinical Research | Rockville | Maryland | 20854 | — |
| DM Clinical Research | Brookline | Massachusetts | 02445 | — |
| University of Massachusetts Chan Medical School | Worcester | Massachusetts | 01655 | — |
| DM Clinical Research | Southfield | Michigan | 48076 | — |
| Velocity Clinical Research | Grand Island | Nebraska | 68803 | — |
| Velocity Clinical Research | Hastings | Nebraska | 68901 | — |
| Velocity Clinical Research | Lincoln | Nebraska | 68510 | — |
| Velocity Clinical Research | Norfolk | Nebraska | 68701 | — |
| Velocity Clinical Research | Omaha | Nebraska | 68134 | — |
| Las Vegas Clinical Trials, LLC | North Las Vegas | Nevada | 89030 | — |
| Velocity Clinical Research | Binghamton | New York | 13905 | — |
| Rochester Clinical Research, Inc | Rochester | New York | 14609 | — |
| Eximia Clinical Research | Raleigh | North Carolina | 27607 | — |
| Tekton Research, Inc | Edmond | Oklahoma | 73013 | — |
| Tekton Research | Moore | Oklahoma | 73160 | — |
| Tekton Research | Oklahoma City | Oklahoma | 73134 | — |
| DM Clinical Research - Philadelphia | Philadelphia | Pennsylvania | 19107 | — |
| Alliance for Multispecialty Research, LLC | Knoxville | Tennessee | 37920 | — |
| Benchmark Research | Austin | Texas | 78705 | — |
| Tekton Research Inc. | Austin | Texas | 78745 | — |
| DM Clinical Research | Houston | Texas | 77065 | — |
| 3A Research | Plano | Texas | 75093 | — |
| DM Clinical Research | Sugar Land | Texas | 77478 | — |
| DM Clinical Research | Tomball | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05831111, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05831111 live on ClinicalTrials.gov.